Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.smspharma.com | |
Market Cap | 713.62 Cr. | |
Enterprise Value(EV) | 958.66 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.83 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 32.05 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 54.40 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.55 | Calculated using Price: 84.41 |
Dividend Yield | 0.36 | Period Ending 2022-03 |
No. of Shares Subscribed | 8.47 Cr. | 84,652,030 Shares |
FaceValue | 1 | |
About SMS Pharmaceuticals Ltd. | ||
SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base. Having six multi product facilities in operation, one under development, and two research centers, SMS has truly graduated in to big league with more than 600 employees working for it. |
1 Day |
|
+1.82% |
1 Week |
|
-0.80% |
1 Month |
|
+4.69% |
3 Month |
|
+22.21% |
6 Month |
|
-0.64% |
1 Year |
|
+3.89% |
2 Year |
|
-47.77% |
5 Year |
|
+33.56% |
10 Year |
|
+237.64% |
8 years | 2007-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 14.11 | 17.57 | 12.99 | 15.00 | 13.67 | 9.76 | 16.07 | 15.41 | |
Return on Capital Employed (%) | 18.91 | 19.54 | 12.73 | 18.17 | 16.57 | 13.06 | 17.62 | 12.60 | |
Return on Assets (%) | 7.73 | 8.46 | 6.15 | 7.95 | 7.62 | 5.50 | 8.44 | 7.97 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 294 | 255 | 284 | 322 | 348 | 411 | 470 | 461 | |
Non Curr. Liab. | 162 | 91 | 97 | 94 | 114 | 206 | 193 | 164 | |
Curr. Liab. | 200 | 156 | 134 | 156 | 154 | 211 | 211 | 255 | |
Minority Int. | |||||||||
Equity & Liab. | 656 | 502 | 515 | 572 | 617 | 828 | 875 | 880 | |
Non Curr. Assets | 408 | 336 | 334 | 351 | 389 | 503 | 482 | 469 | |
Curr. Assets | 248 | 166 | 181 | 221 | 228 | 325 | 392 | 411 | |
Misc. Exp. not W/O | |||||||||
Total Assets | 656 | 502 | 515 | 572 | 617 | 828 | 875 | 880 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 612 | 445 | 465 | 465 | 412 | 563 | 520 | 522 | |
Other Income | 4 | 1 | 2 | 3 | 5 | 3 | 5 | 5 | |
Total Income | 615 | 447 | 467 | 468 | 417 | 567 | 525 | 527 | |
Total Expenditure | -522 | -370 | -372 | -375 | -332 | -442 | -405 | -468 | |
PBIDT | 93 | 77 | 96 | 94 | 85 | 125 | 120 | 59 | |
Interest | -17 | -16 | -15 | -12 | -12 | -11 | -19 | -22 | |
Depreciation | -19 | -19 | -20 | -19 | -22 | -22 | -32 | -32 | |
Taxation | -15 | -6 | -20 | -21 | -18 | -30 | -1 | -1 | |
Exceptional Items | |||||||||
PAT | 42 | 36 | 40 | 41 | 33 | 61 | 68 | 4 | |
Minority Interest | |||||||||
Share Associate | -1 | -7 | -9 | -1 | -1 | 2 | -6 | -9 | |
Other Related Items | |||||||||
Consolidated Net Profit | 41 | 28 | 32 | 40 | 32 | 63 | 62 | -5 | |
Adjusted EPS | 5 | 3 | 4 | 5 | 4 | 7 | 7 | -1 |
Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 61 | 73 | 32 | 50 | 40 | 90 | 40 | |
Cash Fr. Inv. | -97 | -39 | -17 | -35 | -43 | -152 | -27 | |
Cash Fr. Finan. | 44 | -33 | -15 | -13 | -2 | 92 | -7 | |
Net Change | 9 | 1 | 0 | 2 | -5 | 31 | 6 | |
Cash & Cash Eqvt | 11 | 12 | 13 | 15 | 10 | 40 | 47 |
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of the Conference Call held on 26th May 2023. |
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for the financial year 2022-23 |
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for the financial year 2022-2023 |
Thu, 01 Jun 2023 |
|
|
|
|
|